From the Czech desk of MedScopeGlobal. Shared with attribution — the local desk added context for this edition.
Sizing up the benefits of clinical trial data sharingVIP
The potential benefits of sharing clinical trial data are broadly recognised by researchers, policy makers, and the public. Notably, US clinical trial participants express high levels of support for secondary use of their individual participant data (IPD), especially by academic scientists.1 The US National Institutes
The potential benefits of sharing clinical trial data are broadly recognised by researchers, policy makers, and the public. Notably, US clinical trial participants express high levels of support for secondary use of their individual participant data (IPD), especially by academic scientists.1 The US National Institutes
Exkluzivně pro předplatitele
Pokračujte ve čtení s MedScope Premium
VIP články obsahují klinické dopady, klíčové body a ověřené zdroje — navržené pro studenty a lékaře.
14 dní zkušební verze zdarma — vyzkoušejte bez rizika
Prepared by the MedScopeGlobal.com editorial team — educational health content for the public. Always consult a physician for personal medical decisions.
